Autoantibodies against complement C1q (anti-C1q) have been well described in patients with systemic lupus erythematosus, where they correlate with the occurrence of severe lupus nephritis. However, data on anti-C1q in organ-specific autoimmune diseases are scarce. In order to determine the prevalence of anti-C1q in patients with autoimmune thyroid disorders (AITD) and a possible association with thyroid function, we measured prospectively anti-C1q in 23 patients with Graves' disease (GD) and 52 patients with Hashimoto's thyroiditis (HT). Anti-C1q levels were correlated with parameters of thyroid function and autoantibodies against thyroperoxidase, thyroglobulin and thyroid stimulating hormone (TSH) receptor. Twenty-one patients with multi-nodular goitre and 72 normal blood donors served as controls. We found elevated concentrations of anti-C1q more frequently in patients with AITD than in controls: seven of 23 (30%) patients with GD and 11 of 52 (21%) patients with HT, compared with one of 21 (5%) patients with multi-nodular goitre and six of 72 (8%) normal controls. Anti-C1q levels did not correlate with thyroid autoantibodies. However, in GD absolute levels of anti-C1q correlated negatively with TSH and positively with free thyroxine (FT4) and triiodothyronine (FT3). In contrast, in HT, anti-C1q correlated positively with TSH levels. No correlation between TSH and thyroid autoantibodies was found. In conclusion, we found an increased prevalence of anti-C1q in patients with AITD and their levels correlated with the thyroid function in both GD and HT. This correlation seems to be independent of thyroid autoantibodies. Therefore, anti-C1q might point to a pathogenic mechanism involved in the development of AITD that is independent of classical thyroid autoantibodies.

3rd Clinic of Medicine General Teaching Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Blanchin S, Estienne V, Durand-Gorde J, et al. Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology. 2003;144:5422–9. PubMed

Nakai H, Hirakawa S, Hayakawa N, et al. Enhanced expression of complement regulatory proteins on thyroid epithelial cells of Graves' disease. Acta Med Okayama. 1992;46:323–30. PubMed

Kasajima T, Yamakawa M, Imai Y. Immunohistochemical study of intrathyroidal lymph nodes. Clin Immunol Immunopathol. 1987;43:117–28. PubMed

Weetman A, Cohen SB, Oleesky DA, et al. Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease. Clin Exp Immunol. 1989;77:25–30. PubMed PMC

Inoue K, Niesen N, Milgrom F, et al. Transfer of experimental autoimmune thyroiditis by in situ perfusion of thyroids with immune sera. Clin Immunol Immunopathol. 1993;66:11–17. PubMed

Nielsen CH, Hegedus L, Leslie RG. Autoantibodies in autoimmune thyroid disease promote immune complex formation with self antigens and increase B cell and CD4+ T cell proliferation in response to self antigens. Eur J Immunol. 2004;34:263–72. PubMed

Parkes A, Othman S, Hall R, et al. The role of complement in the pathogenesis of postpartum thyroiditis. J Clin Endocrinol Metab. 1994;79:395–400. PubMed

Tandon N, Yan SL, Morgan BP, et al. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease. Immunology. 1994;81:643–7. PubMed PMC

Weetman A, Freeman M, Morgan BP. Thyroid follicular cell function after non-lethal complement membrane attack. Clin Exp Immunol. 1990;82:69–74. PubMed PMC

Weetman A, Tandon N, Morgan BP. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet. 1992;340:633–6. PubMed

Potlukova E, Kralikova P. Complement component C1q and anti-C1q antibodies in theory and in clinical practice. Scand J Immunol. 2008;20:13. PubMed

Siegert CEH, Kazatchkine MD, Sjöholms A, et al. Autoantibodies aganst C1q: view on clinical relevance and pathogenic roles. Clin Exp Immunol. 1999;116:4–8. PubMed PMC

Trendelenburg M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol. 2005;27:276–85. PubMed

Wisnieski J, Jones SM. IgG autoantibody to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus and six other skeletal or rheumatic diseases. J Rheumatol. 1992;19:884–8. PubMed

Siegert CEH, Daha MR, Westedt ML, et al. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol. 1991;18:230–4. PubMed

Siegert CEH, Daha MR, Tseng CMES, et al. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis. 1993;52:851–6. PubMed PMC

Trendelenburg M, Courvoisier S, Spaeth PJ, et al. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis. 1999;34:745–51. PubMed

Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant. 2006;21:3115–21. PubMed

Kozyro I, Perahud I, Sadallah S, et al. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics. 2006;117:1663–8. PubMed

Carle A, Laurberg P, Knudsen N, et al. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity. 2006;39:497–503. PubMed

Hooogendoorn EH, Hermus AR, De Vegt F, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem. 2006;52:104–11. PubMed

Strieder TG, Prummel MF, Tijssen JG, et al. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol. 2003;59:396–401. PubMed

Weetman AP. Graves' disease. N Engl J Med. 2000;343:1236–48. PubMed

Weetman AP. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol. 2004;61:405–13. PubMed

Flierman R, Daha MR. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis − a hypothesis. Mol Immunol. 2007;44:133–8. PubMed

Nielsen CH, Moeller AN, Hegedus L, et al. Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease: increased frequency of thyroglobulin-reactive cells in Graves' disease. J Clin Immunol. 2006;26:126–36. PubMed

Okosieme O, Parkes AB, McCullough B, et al. Complement activation in postpartum thyroiditis. Q J Med. 2002;95:173–9. PubMed

Parkes A, Othman S, Hall R, et al. Role of complement in the pathogenesis of postpartum thyroiditis: relationship between complement activation and disease presentation and progression. Eur J Endocrinol. 1995;133:210–15. PubMed

Parkes A, Adams H, Othman S, et al. The role of complement in the pathogenesis of postpartum thyroiditis: ultrasound echogenicity and the degree of complement-induced thyroid damage. Thyroid. 1996;6:177–82. PubMed

Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women